ACADIA Pharmaceuticals Funding & Investors
Pharmaceutical company, which developed Nuplazid, based in San Diego, California.
acadia-pharm.comTotal Amount Raised: $121,600,000
ACADIA Pharmaceuticals Funding Rounds
Series F
$25,000,000
Series F Investors
Federated HermesHambrecht & Quist Capital ManagementForbionOxford Bioscience PartnersOrbiMed AdvisorsABN AMRO BankLD PensionsPost Ipo Equity
$86,385,000
Post Ipo Equity
$287,500,000
Post Ipo Equity
$316,249,997
Debt Financing
$22,000,000
Debt Financing Investors
Pacific Rim VenturesH&Q Healthcare InvestorsThe Kaufman FundOrbiMed AdvisorsDKA CapitalPost Ipo Equity
$15,000,000
Post Ipo Equity Investors
New Enterprise Associates (NEA)VenrockSeries D
$10,700,000
Series D Investors
DKA CapitalLD PensionsPost Ipo Equity
$287,500,000
Post Ipo Equity
$316,249,997
Grant
$2,400,000
Grant Investors
National Institute of Neurological Disorders and Stroke (NINDS)Debt Financing
$7,500,000
Debt Financing Investors
VækstfondenPost Ipo Equity
$20,000,000
Post Ipo Equity Investors
NomuraOxford Bioscience PartnersPost Ipo Equity
$10,000,000
Post Ipo Equity Investors
Oxford Bioscience PartnersSeries B
$3,000,000
Series B Investors
BankInvestDKA CapitalLD PensionsSeries A
$6,000,000
Series A Investors
BankInvestDKA CapitalLD Pensions
Funding info provided by Diffbot.